Asia-Pacific Contraceptives Market

Date : Sep 2019

Formats :
Report Code : PMR324009849

Category : Pharmaceutical and Healthcare
No Of Pages : 190

Asia-Pacific Contraceptives Market

Asia-Pacific Contraceptives Market Overview:

In 2016, the APAC contraceptive market is estimated at $1.36 billion. This market will reach USD 1.988 billion by the end of 2021. The market is expected to grow at 7.74% in this period.

Asia-Pacific Contraceptives Market Dynamics:

The study details several variables driving and restraining the respiratory device market. Some are mentioned below.

Asia-Pacific Contraceptives Market Drivers:

Contributing to global contraceptive market growth is the need to prevent unwanted pregnancies and complications. One of the main drivers for this industry is the need to prevent unwanted pregnancies, particularly in adolescent females. More than half of females also find non-contraceptive health advantages, such as therapy for excessive menstrual bleeding, menstrual pain, and acne, as reasons for use. This is also one factor contributing to market growth. The other variables contributing to contraceptive market growth are the growing incidence of STDs and rapid population growth. Government initiatives encouraging contraceptives to prevent unnecessary births and the health advantages of using contraceptives were also significant players in market growth.

Asia-Pacific Contraceptives Market Restraints:

Factors like religious and cultural resistance in some emerging nations have restrained this market s development. In addition, the fear of certain side effects and problems such as infertility arising from contraception use have been significant market-based setbacks. Issues like restricted access to contraception in developing and economically backward countries were another setback in this market. It is estimated that among APAC females, the need for contraceptive incidence or family planning needs is as large as 11%.

The APAC market for contraceptive drugs and devices can be segmented based on contraceptive technique, delivery mode, device type, ethnicity and geography. The market is segmented into pills, implants, sterilization, IUDs, injectable, male condoms, vaginal barrier methods, etc. The market is segmented into oral, topical and contraceptive injection based on delivery mode. The device-based market is segmented into condoms, diaphragms, cervical caps, sponges, and vaginal rings.

Geographically, it maintains the biggest market share of Asia-Pacific. Over 70% of APAC s female population utilizes contemporary contraceptive methods. APAC s contraceptive prevalence is estimated at 67%. Emerging nations have recently shown increased contraceptive incidence. There s, however, a big population with unmet contraceptive requirements. This makes hot destinations for contraceptives emerging countries.

Some of the key players in the market are:

Merck & Co., Mylan Laboratories, Pfizer, The Female Health Company.
CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Product Innovation
4.1.2. Increasing incidence of STD s
4.1.3. Pregnancy prevention
4.1.4. Immediate Health benefits other than birth control
4.1.5. Rise in Government initiatives to prevent unwanted abortions and pregnancies
4.1.6. Rapid increase in global population
4.2. Market Restraints
4.2.1. Fear or experience of side effects
4.2.2. Cultural or Religious opposition
4.2.3. Limited access to contraception
4.2.4. Infertility issues
4.2.5. Economic constraints
4.3. Market Opportunities
4.3.1. New product pipelines
4.3.2. Male Contraceptive Drugs
4.4. Market Challenges
CHAPTER 5 ASIA-PACIFIC CONTRACEPTIVES MARKET – BY CONTRACEPTIVE METHOD
5.1. Sterilization
5.2. Pills
5.3. Implants
5.4. Injectables
5.5. Intrauterine Device IUD
5.6. Male Condoms
5.7. Vaginal barrier methods
5.8. Others
CHAPTER 6 ASIA-PACIFIC CONTRACEPTIVES MARKET - BY MODE OF DELIVERY
6.1. Oral Contraceptives
6.2. Topical Contraceptives
6.3. Contraceptive Injectables
CHAPTER 7 ASIA-PACIFIC CONTRACEPTIVES MARKET - BY TYPE OF DEVICE
7.1. Condoms
7.2. Diaphragms
7.3. Cervical Caps
7.4. Sponges
7.5. Vaginal Rings
7.6. IUD
7.7. Implants
CHAPTER 8 ASIA-PACIFIC CONTRACEPTIVES MARKET - BY GEOGRAPHY
8.1. Male
8.2. Female
CHAPTER 9 ASIA-PACIFIC CONTRACEPTIVES MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. Asia Pacific
9.2.1. China
9.2.2. Japan
9.2.3. India
9.2.4. South Korea
9.2.5. Australia & New Zealand
9.2.6. Malaysia
9.2.7. Singapore
9.2.8. Others
CHAPTER 10 ASIA-PACIFIC CONTRACEPTIVES MARKET - COMPANY PROFILES
10.1 Bayer Healthcare
10.2 Pfizer
10.3 Merck & Co
10.4 Teva Pharmaceuticals, Ltd
10.5 Agile Therapeutics
10.6 Actavis PLC
10.7 ANI Pharmaceuticals, Inc.
10.8 Church & Dwight, Co. Inc
10.9 Fuji Latex Co., Ltd
10.10 Johnson & Johnson, Ltd
10.11 Lupin Pharmaceuticals, Ltd
10.12 Okamato Industries, Inc.
10.13 Reckitt Benckiser Group, PLC
10.14 The Female Health Company
10.15 Mylan Laboratories
CHAPTER 11 ASIA-PACIFIC CONTRACEPTIVES MARKET - COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
  Purchase Options for Report

Need More information

Call us :
USA : +1 7162260907
UK : +44 7441952057
....
sales@planetmarketreports.com

Why to choose PMR

PMR Market Research

Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.

  • Industrial ...
  • Business ....
  • Consumer ....
  • Peer ....

About Report

Planet Market Reports added Latest and detailed market study report that focuses on “Asia-Pacific Contraceptives Market" Which offers essential information based on fresh ideas into Asia-Pacific Contraceptives Market industry along with unique market analysis which covers current top Manufactures in Asia-Pacific Contraceptives Market, growth, Consumption Demand, challenges, Historical data, subjects wise Survey of each chapters, Regional Insights, and Advancing industry trends, which will help our clients to aim Asia-Pacific Contraceptives Market. In addition, the report helps the customers to get a brief idea about Future demand and specifications of products which ensures the driving long-term income and productivity of global market.